T Chase Francis1, Ramesh Chandra1, Danielle M Friend2, Eric Finkel1, Genesis Dayrit3, Jorge Miranda4, Julie M Brooks1, Sergio D Iñiguez5, Patricio O'Donnell1, Alexxai Kravitz2, Mary Kay Lobo6. 1. Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore. 2. Diabetes, Endocrinology, and Obesity Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland. 3. Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore.; Department of Psychology, California State University, San Bernardino, California. 4. Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore.; Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, Mexico. 5. Department of Psychology, California State University, San Bernardino, California. 6. Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore.. Electronic address: mklobo@umaryland.edu.
Abstract
BACKGROUND: The nucleus accumbens is a critical mediator of depression-related outcomes to social defeat stress. Previous studies demonstrate distinct neuroplasticity adaptations in the two medium spiny neuron (MSN) subtypes, those enriched in dopamine receptor D1 versus dopamine receptor D2, in reward and reinforcement leading to opposing roles for these MSNs in these behaviors. However, the distinct roles of nucleus accumbens MSN subtypes, in depression, remain poorly understood. METHODS: Using whole-cell patch clamp electrophysiology, we examined excitatory input to MSN subtypes and intrinsic excitability measures in D1-green fluorescent protein and D2-green fluorescent protein bacterial artificial chromosome transgenic mice that underwent chronic social defeat stress (CSDS). Optogenetic and pharmacogenetic approaches were used to bidirectionally alter firing of D1-MSNs or D2-MSNs after CSDS or before a subthreshold social defeat stress in D1-Cre or D2-Cre bacterial artificial chromosome transgenic mice. RESULTS: We demonstrate that the frequency of excitatory synaptic input is decreased in D1-MSNs and increased in D2-MSNs in mice displaying depression-like behaviors after CSDS. Enhancing activity in D1-MSNs results in resilient behavioral outcomes, while inhibition of these MSNs induces depression-like outcomes after CSDS. Bidirectional modulation of D2-MSNs does not alter behavioral responses to CSDS; however, repeated activation of D2-MSNs in stress naïve mice induces social avoidance following subthreshold social defeat stress. CONCLUSIONS: Our studies uncover novel functions of MSN subtypes in depression-like outcomes. Notably, bidirectional alteration of D1-MSN activity promotes opposite behavioral outcomes to chronic social stress. Therefore, targeting D1-MSN activity may provide novel treatment strategies for depression or other affective disorders.
BACKGROUND: The nucleus accumbens is a critical mediator of depression-related outcomes to social defeat stress. Previous studies demonstrate distinct neuroplasticity adaptations in the two medium spiny neuron (MSN) subtypes, those enriched in dopamine receptor D1 versus dopamine receptor D2, in reward and reinforcement leading to opposing roles for these MSNs in these behaviors. However, the distinct roles of nucleus accumbens MSN subtypes, in depression, remain poorly understood. METHODS: Using whole-cell patch clamp electrophysiology, we examined excitatory input to MSN subtypes and intrinsic excitability measures in D1-green fluorescent protein and D2-green fluorescent protein bacterial artificial chromosome transgenic mice that underwent chronic social defeat stress (CSDS). Optogenetic and pharmacogenetic approaches were used to bidirectionally alter firing of D1-MSNs or D2-MSNs after CSDS or before a subthreshold social defeat stress in D1-Cre or D2-Cre bacterial artificial chromosome transgenic mice. RESULTS: We demonstrate that the frequency of excitatory synaptic input is decreased in D1-MSNs and increased in D2-MSNs in mice displaying depression-like behaviors after CSDS. Enhancing activity in D1-MSNs results in resilient behavioral outcomes, while inhibition of these MSNs induces depression-like outcomes after CSDS. Bidirectional modulation of D2-MSNs does not alter behavioral responses to CSDS; however, repeated activation of D2-MSNs in stress naïve mice induces social avoidance following subthreshold social defeat stress. CONCLUSIONS: Our studies uncover novel functions of MSN subtypes in depression-like outcomes. Notably, bidirectional alteration of D1-MSN activity promotes opposite behavioral outcomes to chronic social stress. Therefore, targeting D1-MSN activity may provide novel treatment strategies for depression or other affective disorders.
Authors: Alexxai V Kravitz; Benjamin S Freeze; Philip R L Parker; Kenneth Kay; Myo T Thwin; Karl Deisseroth; Anatol C Kreitzer Journal: Nature Date: 2010-07-07 Impact factor: 49.962
Authors: Vincent Vialou; Alfred J Robison; Quincey C Laplant; Herbert E Covington; David M Dietz; Yoshinori N Ohnishi; Ezekiell Mouzon; Augustus J Rush; Emily L Watts; Deanna L Wallace; Sergio D Iñiguez; Yoko H Ohnishi; Michel A Steiner; Brandon L Warren; Vaishnav Krishnan; Carlos A Bolaños; Rachael L Neve; Subroto Ghose; Olivier Berton; Carol A Tamminga; Eric J Nestler Journal: Nat Neurosci Date: 2010-05-16 Impact factor: 24.884
Authors: Jonathan P Britt; Faiza Benaliouad; Ross A McDevitt; Garret D Stuber; Roy A Wise; Antonello Bonci Journal: Neuron Date: 2012-11-21 Impact factor: 17.173
Authors: Shiaoching Gong; Chen Zheng; Martin L Doughty; Kasia Losos; Nicholas Didkovsky; Uta B Schambra; Norma J Nowak; Alexandra Joyner; Gabrielle Leblanc; Mary E Hatten; Nathaniel Heintz Journal: Nature Date: 2003-10-30 Impact factor: 49.962
Authors: Ramesh Chandra; Jeffrey D Lenz; Amy M Gancarz; Dipesh Chaudhury; Gabrielle L Schroeder; Ming-Hu Han; Joseph F Cheer; David M Dietz; Mary Kay Lobo Journal: Front Mol Neurosci Date: 2013-05-24 Impact factor: 5.639
Authors: Praneeth Namburi; Ream Al-Hasani; Gwendolyn G Calhoon; Michael R Bruchas; Kay M Tye Journal: Neuropsychopharmacology Date: 2015-12-09 Impact factor: 7.853
Authors: Audrey E Padula; William C Griffin; Marcelo F Lopez; Sudarat Nimitvilai; Reginald Cannady; Natalie S McGuier; Elissa J Chesler; Michael F Miles; Robert W Williams; Patrick K Randall; John J Woodward; Howard C Becker; Patrick J Mulholland Journal: Neuropsychopharmacology Date: 2015-02-09 Impact factor: 7.853
Authors: Thibaut R Pardo-Garcia; Constanza Garcia-Keller; Tiffany Penaloza; Christopher T Richie; James Pickel; Bruce T Hope; Brandon K Harvey; Peter W Kalivas; Jasper A Heinsbroek Journal: J Neurosci Date: 2019-01-08 Impact factor: 6.167
Authors: Oakleigh M Folkes; Rita Báldi; Veronika Kondev; David J Marcus; Nolan D Hartley; Brandon D Turner; Jade K Ayers; Jordan J Baechle; Maya P Misra; Megan Altemus; Carrie A Grueter; Brad A Grueter; Sachin Patel Journal: J Clin Invest Date: 2020-04-01 Impact factor: 14.808
Authors: Hyungwoo Nam; Ramesh Chandra; T Chase Francis; Caroline Dias; Joseph F Cheer; Mary Kay Lobo Journal: Neuropsychopharmacology Date: 2019-05-27 Impact factor: 7.853